ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Plasmablasts"

  • Abstract Number: 124 • 2019 ACR/ARP Annual Meeting

    Treatment with Abatacept but Not with TNF Blockers, Is Associated with a Reduction of Constitutively Elevated Circulating Follicular Helper T Cells in Rheumatoid Arthritis

    Maria-Eugenia Miranda-Carus1, Paula Fortea-Gordo 2, Laura Nuño 3, Alejandro Villalba 4, Maria-Jose Santos-Bornez 2, Diana Peiteado 2, Irene Monjo 1 and Alejandro Balsa 5, 1FIBHULP-IdiPAZ-Hospital La Paz-Rheumatology, Madrid, Spain, 2FIBHULP-IdiPAZ-Hospital La Paz, Madrid, Spain, 3Rheumatology Department, Hospital Universitario La Paz, Madrid, Spain, Madrid, Spain, 4FIBHULP-IdiPAZ-Hospital La Paz-Rheumatology, Madrid, 5Immuno-Rheumatology Research Group, IdiPaz & Rheumatology Department. La Paz University Hospital, Madrid, Spain

    Background/Purpose: Circulating CD4 T cells that express CXCR5 together with PD-1 and/or ICOS are considered as counterparts of bona fide Tfh cells and function as…
  • Abstract Number: 2791 • 2018 ACR/ARHP Annual Meeting

    Characterization of Monoclonal Anti-PAD4 Autoantibodies from Rheumatoid Arthritis Patients: Functional Implications for Citrullination and Disease Progression

    Alejandro Gomez, Sarah Kongpachith, Nithya Lingampalli, Cecilia Cisar and William H. Robinson, Department of Medicine, Stanford University, Stanford, CA

    Background/Purpose: Anti-citrullinated protein antibodies (ACPA) are present in two-thirds of patients with rheumatoid arthritis (RA), and target proteins that have been post-translationally modified by the…
  • Abstract Number: 2947 • 2018 ACR/ARHP Annual Meeting

    Peripheral Helper T Cells in Systemic Lupus Erythematosus

    Ayako Makiyama1,2, Asako Chiba1, Goh Murayama3, Ken Yamaji3, Naoto Tamura3 and Sachiko Miyake1, 1Immunology, Juntendo University School of Medicine, Tokyo, Japan, 2Department of Internal Medicine and Rheumatology, Juntendo University School of Medicine, Tokyo, Japan, 3Internal Medicine and Rheumatology, Juntendo University School of Medicine, Tokyo, Japan

    Background/Purpose: Autoreactive T-B cell interactions in lymphoid tissue have been thought to play a crucial role in the autoantibody production in systemic lupus erythematosus (SLE).…
  • Abstract Number: 30 • 2017 ACR/ARHP Annual Meeting

    Specificity of Salivary Gland-Derived Monoclonal Antibodies from Sjogren’s Syndrome Patients Using Human Proteome Arrays

    Sherri Longobardi1, Christina Lawrence2, Kristi A. Koelsch3, Kenneth Smith2, Constantin Georgescu2, Michelle L. Joachims2, Lida Radfar4, Astrid Rasmussen2, Kathy L. Sivils2, Jonathan Wren2, R. Hal Scofield2 and A. Darise Farris2, 1Graduate Program in Biological Sciences, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 2Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, 3Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Okalahoma City, OK, 4Department of Oral Diagnosis and Radiology, University of Oklahoma College of Dentistry, Oklahoma City, OK

    Background/Purpose: Sjögren’s syndrome (SS) is a rheumatic autoimmune disease characterized by focal lymphocytic infiltrations in the lacrimal and salivary glands, autoantibodies to the ubiquitous Ro…
  • Abstract Number: 1882 • 2017 ACR/ARHP Annual Meeting

    Thymus and Activation-Regulated Chemokine (TARC) As Biomarker for IgG4-Related Disease

    Masataka Umeda1,2, Tomoki Origuchi3, Shinya Kawashiri1,4, Tomohiro Koga1,5, Kunihiro Ichinose1, Yushiro Endo1, Sousuke Tsuji1, Ayuko Takatani1, Takashi Igawa1, Toshimasa Shimizu1, Shoichi Fukui1,4, Remi Sumiyoshi1, Ayako Nishino1,6, Naoki Iwamoto1, Mami Tamai1, Hideki Nakamura1 and Atsushi Kawakami1, 1Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan, 2Medical Education Development Center, Nagasaki University Hospital, Nagasaki, Japan, 3Department of Rehabilitation Sciences, Nagasaki University, Nagasaki, Japan, 4Departments of Community Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan, 5Center for Bioinformatics and Molecular Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki City, Japan, 6Center for Comprehensive Community Care Education, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan

    Background/Purpose: TARC, also known as chemokine ligand 17 (CCR17), is expressed in the thymus and is produced by dendritic cells, endothelial cells, keratinocytes and fibroblasts.…
  • Abstract Number: 2426 • 2017 ACR/ARHP Annual Meeting

    Altered Frequencies of Circulating Follicullar T Helper Cell Counterparts and Their Subsets but Not of Peripheral Helper T Cells, Are Associated with Increased Circulating Plasmablasts in Seropositive Early RA Patients

    Paula Fortea-Gordo1, Lorena Valdeolivas-De Opazo1, Laura Nuño2, Alejandro Villalba1, Paloma Sanchez-Mateos3, Amaya Puig-Kröger4, Alejandro Balsa1 and Maria Eugenia Miranda-Carus1, 1Rheumatology, Hospital La Paz-IdiPAZ, Madrid, Spain, 2Rheumatology, La Paz University Hospital, Madrid, Spain, 3Immunology, Hospital Gregorio Marañon, Madrid, Spain, 4Immuno-oncology, Hospital Gregorio Marañon, Madrid, Spain

    Background/Purpose: Follicular T helper (Tfh) cells are typically located in lymphoid organs where they promote B cell differentiation and function. Circulating CD4 T cells expressing…
  • Abstract Number: 2639 • 2017 ACR/ARHP Annual Meeting

    Pathological Relevance of T Follicular Helper Cell and Plasmablast in Patients with Systemic Lupus Erythematosus

    Shingo Nakayamada1, Satoshi Kubo2, Maiko Yoshikawa2, Yusuke Miyazaki2, Shigeru Iwata3, Ippei Miyagawa4, Shunsuke Fukuyo5, Kazuhisa Nakano1 and Yoshiya Tanaka6, 1First Department of Internal Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan, 2The First Department of Internal Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan, 3First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan, 4University of Occupational and Environmental Health, Japan, Kitakyushu, Japan, 5University of Occupational and Environmental Health, Japan, Fukuoka, Japan, 6The First Department of Internal Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan

    Background/Purpose: Increasing evidence points to immunological heterogeneity in the pathogenesis of SLE. Indeed, targeted therapy for SLE showed considerable variability of efficacy. Thus, it seems…
  • Abstract Number: 666 • 2016 ACR/ARHP Annual Meeting

    Immunoglobulin N-Glycosylation Acquired By Somatic Hypermutation As a Potential Mechanism for Non-Specific B Cell Activation in Sjogren’s Syndrome

    Kristi A. Koelsch1,2,3, Joshua Cavett4,5, Jacen Maier-Moore6, Kenneth Smith5, Christopher Lessard4,7,8, Lida Radfar9, David M. Lewis10, Biji T Kurien1,4,5, Astrid Rasmussen7, Kathy Sivils5,8, Judith A. James4,7,8, A. Darise Farris7 and R. Hal Scofield1,7,11, 1U.S. Department of Veterans Affairs Medical Center, Oklahoma City, OK, 2Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Okalahoma City, OK, 3Endocrinology and Diabetes, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 4College of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 5Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, 6Dept. of Clinical Laboratory Science, University of Texas at El Paso, El Paso, TX, 7Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, 8Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 9Oral Diagnosis and Radiology Department, University of Oklahoma College of Dentistry, Oklahoma City, OK, 10Department of Oral and Maxillofacial Pathology, University of Oklahoma College of Dentistry, Oklahoma City, OK, 11College of Medicine, Section of Endocrinology and Diabetes, University of Oklahoma Health Sciences Center, Oklahoma City, OK

    Background/Purpose: Sjögren’s syndrome (SS) is a systemic autoimmune disease characterized by lymphocytic infiltration of the salivary and lacrimal glands resulting in tissue destruction, pathological dry…
  • Abstract Number: 1286 • 2016 ACR/ARHP Annual Meeting

    Inflammatory Activity of IgG4-Related Disease Lesions Assessed By Quantitative Positron Emission Tomography Correlates with Circulating Plasmablasts Levels

    Alvise Berti1, Carla Canevari2, Francesca Gallivanone3, Marco Lanzillotta4, Emanuele Bozzalla Cassione4, Corrado Campochiaro5, Giuseppe Alvise Ramirez4, Maria Grazia Sabbadini4 and Emanuel Della Torre4, 1Internal Medicine and Clinical Immunology, Vita-Salute San Raffaele University, Milan, Italy, 2Nuclear Medicine, San Raffaele Scientific Institute, Milan, Italy, 3Consiglio Nazionale delle Ricerche, IBFM, Milan, Italy, 4Unit of Medicine and Clinical Immunology, San Raffaele Scientific Institute, Milan, Italy, 5San Raffaele Scientific Institute, Milan, Italy

    Background/Purpose:  18-Fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) scan is emerging as a promising imaging technique for diagnosis and staging of IgG4-RD. We aim to correlate…
  • Abstract Number: 2861 • 2016 ACR/ARHP Annual Meeting

    Proportions of Circulating Follicular Helper T Cells and Complement Levels, White Blood Cell Counts, and Skin Manifestations in Patients with Active Systemic Lupus Erythematosus

    Jun Kikuchi1, Masaru Takeshita1, Katsuya Suzuki2, Yoshiaki Kassai3, Takahiro Miyazaki3 and Tsutomu Takeuchi2, 1Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan, 2Keio University School of Medcine, Division of Rheumatology, Department of Internal Medicine, Tokyo, Japan, 3Inflammation Drug Discovery Unit, Pharmaceutical Research Division, Takeda Pharmaceutical Company Ltd., Kanagawa, Japan

    Background/Purpose:  Although circulating B cells and T cells, including follicular helper T (Tfh) cells, are reported to be involved in systemic lupus erythematosus (SLE) 1,2),…
  • Abstract Number: 2040 • 2015 ACR/ARHP Annual Meeting

    T Follicular Helper like CD4+CXCR5+pd-1+ Cells and T Follicular Helper like Type 2 Cells Subsets Are Increased in IgG4-Related Disease Patients

    Aurélie Grados1, Mikael Ebbo1, Christelle Piperoglou2, Matthieu Groh3, Alexis Regent4, Maxime Samson5, Benjamin Terrier6, Nathalie Morel7, Sylvain Audia5, Francois Maurier8, Julie Graveleau9, Mohamed Hamidou10, Amandine Forestier11, Sylvain Palat12, Emanuelle Bernit1, Gilles Kaplanski13, Frederique Retornaz14, Bernard Bonotte15, Catherine Farnarier16, Jean-Robert Harle17, Nathalie Costedoat-Chalumeau7, Frederic Vely18 and Nicolas Schleinitz1, 1Internal Medicine, Aix-Marseille Université, AP-HM, Marseille, France, 2Immunology, CIML, AP-HM, Marseille, France, 3National Referral Center for Rare Systemic Autoimmune Diseases, Hôpital Cochin, AP–HP, Université Paris Descartes, Paris, France, 4Service de médecine interne, Hôpital Cochin, Paris, France, 5Department of Internal Medicine and Clinical Immunology, Dijon University Hospital, Dijon, France, 6Internal Medicine, National Referral Center for Rare Systemic Autoimmune Diseases, Hôpital Cochin, Paris, France, 7Internal Medicine Department, Cochin Hospital, “René-Descartes Paris V” University, Paris, France, 8Medecine Interne, Metz, France, 9Medecine Interne Hotel Dieu Nantes, Nantes, France, 10Internal Medicine Department, Nantes University Hospital, Nantes, France, 11Internal Medicine, Groupe Hospitalier Mutualiste de Grenoble, Grenoble, France, 12Service de Medecine Interne, CHU limoges, Limoges, France, 13Internal Medicine hopital conception, Aix-Marseille Université, Marseille, France, 14Conseil General 13 cellule recherche, Marseille, France, 15Department of Internal medicine and Clinicla Immunology Dijon University Hospital, Dijon, France, 16Laboratoire d'immunologie, Hopital de la Conception, Marseille, France, 17Internal Medicine, Aix-Marseille Université, APHM, Marseille, France, 18CIML, Laboratoire d'Immunologie Conception AP-HM, Aix-Marseille université, Marseille, France

    Background/Purpose: IgG4 related disease (IgG4-RD) is associated with characteristic pathological changes including lymphoplasmocytic infiltration with abundant IgG4 positive plasma cells, storiform fibrosis and obliterative phlebitis.…
  • Abstract Number: 1120 • 2015 ACR/ARHP Annual Meeting

    Analysis of SLE Plasmablasts By High Throughput Pairing of the Immunoglobulin Heavy and Light Chain (VH-VL)

    Deepak Tomar1, Christopher Tipton1 and Ignacio Sanz2, 1Medicine/Rheumatology, Emory University School of Medicine, Atlanta, GA, 2Rheumatology, Emory University School of Medicine, Atlanta, GA

    Background/Purpose: In-depth analysis of the molecular and antigenic properties of antibody secreting cells (ASC) is critical for our understanding of autoimmune diseases.  This goal however…
  • Abstract Number: 1953 • 2014 ACR/ARHP Annual Meeting

    Circulating Plasmablasts from Patients with Systemic Lupus Erythematosus Produce Autoantibodies Reactive to Epstein-Barr Virus

    Yangsheng Yu1, Song Li1, Run Fan2, Yinshi Yue1, Hongyan Liao1, Zhixin Wang1, Lin Huang1, Qin Wang3, Michelene Hearth-Holmes4, Amy Cannella5, W. Winn Chatham6, Robert Kimberly2,7, James O'Dell8, Lynell Klassen5, Robert Carter7, Zhixin Zhang9,10 and Kaihong Su1,5,10, 1Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE, 2Department of Microbiology, University of Alabama at Birmingham, Birmingham, AL, 3Shanghai Fengxian District Central Hospital, Shanghai Jiao Tong University, Shanghai, China, 4Internal Medicine/Rheumatology Division, University of Nebraska Medical Center, Omaha, NE, 5Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, 6University of Alabama at Birmingham, Birmingham, AL, 7Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, 8University of Nebraska Medical Center, Omaha, NE, 9Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE, 10Eppley Cancer Institute, University of Nebraska Medical Center, Omaha, NE

    Background/Purpose: Systemic lupus erythematosus (SLE) is characterized by the over-production of high affinity autoantibodies. It is not clear how such autoantibodies are generated during the…
  • Abstract Number: 1238 • 2014 ACR/ARHP Annual Meeting

    Proportion of Peripheral Plasmacytoid Dendritic Cells and Plasmablasts Reflects Disease Activity in IgG4-related Disease

    Mitsuhiro Akiyama1, Katsuya Suzuki1, Yoshiaki Kassai2, Takahiro Miyazaki2, Rimpei Morita3, Akihiko Yoshimura3 and Tsutomu Takeuchi1, 1Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan, 2Inflammation Drug Discovery Unit, Takeda Pharmaceutical Company Limited, Kanagawa, Japan, 3Department of Microbiology and Immunology, Keio University School of Medicine, Tokyo, Japan

    Background/Purpose Immunoglobulin (Ig) G4-related disease (IgG4-RD) is a recently recognized fibro-inflammatory disease with multi-organ system involvement. Affected patients frequently have a history of bronchial asthma and allergic rhinitis. The reported pathogenesis of IgG4-RD describes the clear involvement of excessive Th2 cells and regulatory immune reaction in addition to plasma cells 1). However, peripheral immune cell phenotype, which reflects disease status, has not been comprehensively evaluated. Our aim was to definitively determine peripheral blood cell abnormalities and their correlation with disease activity in patients with IgG4-RD.Methods Peripheral blood samples were obtained from active untreated IgG4-RD patients (n=11) and healthy controls (n=16). Comprehensive immunophenotyping assay with information on activation status was done by multi-color flow cytometry, and the proportion of peripheral blood mononuclear cells (PBMCs), including T cells (naïve/memory, Th1/2/17, Treg, and Tfh), B cells (naïve/memory, plasmablast, Breg), monocytes (classical, intermediate, non-classical) and dendritic cells (myeloid, plasmacytoid), and their activity status were precisely defined. Disease activity was measured using the IgG4-RD responder index (RI). Statistical analysis was done using the Mann-Whitney U test and Spearman rank correlation coefficient test.Results The proportion of plasmablasts (CD19+CD20-CD27+CD38+), memory Th2 cells (CD3+CD4+CXCR3-CCR6-CD45RA-), Tregs (CD3+CD4+CD25+CD127low), Tfh (CD3+CD4+CXCR5+), and mDCs (CD3-CD19-CD14-HLA-DR+CD1c+CD303-) in peripheral blood was significantly increased in IgG4-RD patients compared with HC, whereas the proportion of pDCs (CD3-CD19-CD14-HLA-DR+CD1c-CD303+)was significantly decreased. Interestingly, the proportion of pDCs in total DCs was negatively correlated with IgG4-RD RI (r=-0.778, p=0.005) while the proportion of plasmablasts in CD19+cells was positively correlated with RI (r=0.701, p=0.016). Further, the increased proportion of plasmablasts was positively correlated with serum IgG4 level (r=0.718, p=0.013) while the decreased proportion of pDCs tended to be negatively correlated with the number of affected organs (r=-0.518, p=0.061). Conclusion Our comprehensive analysis identified distinct proportional changes in PBMCs in IgG4-RD. In particular, the decrease in pDCs and increase in plasmablasts were strongly linked with disease activity. These combined measurements are expected to be clinically useful surrogate cell markers. This newly identified decrease in circulating pDCs may be involved in the pathogenesis in IgG4-RD via the recently described role in the enhancement of Th2 response 2).References: 1) Stone JH et.al. N Engl J Med 2012;366:539-51            2) Maazi H et.al. Allergy 2013;68:695-701
  • Abstract Number: 605 • 2014 ACR/ARHP Annual Meeting

    Decreased Frequencies of Circulating Follicular Helper T Cell Counterparts and Plasmablasts in Ankylosing Spondylitis Patients Naïve for TNF Blockers

    M. Belén Bautista-Caro1, Irene Arroyo-Villa1, Concepcion Castillo-Gallego1, Eugenio De Miguel2, Diana Peiteado1, Chamaida Plasencia-Rodriguez1, Alejandro Villalba1, Paloma Sanchez-Mateos3, Amaya Puig-Kröger4, Emilio Martín-Mola1 and Maria Eugenia Miranda-Carus1, 1Rheumatology, Hospital La Paz - IdiPaz, Madrid, Spain, 2Rheumatology, University Hospital La Paz - IdiPaz, Madrid, Spain, 3Immunology, Hospital Gregorio Marañon, Madrid, Spain, 4Laboratorio de Inmuno-Metabolismo, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain

    Background/Purpose: Follicular helper T cells (Tfh), localized in lymphoid organs, promote B cell differentiation and function. Circulating CD4 T cells expressing CXCR5, ICOS and/or PD-1…
  • 1
  • 2
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology